Leaflet MUCOTREIS 50mg / ml syrup


Indicated for: respiratory disorders with viscous secretions

Substance: carbocisteine (mucolytic)

ATC: R05CB03 (Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics)

Carbocisteine is a mucolytic agent used to thin and loosen thick, viscous mucus in the airways, making it easier to expel. It is indicated for the treatment of respiratory conditions such as chronic bronchitis, sinusitis, or other obstructive lung diseases.

Carbocisteine works by reducing mucus viscosity, helping to relieve productive cough and improve breathing. It is available in syrup or capsule form and can be administered to both adults and children, depending on the recommended dosage.

Side effects are rare but may include nausea, stomach discomfort, or allergic reactions. It is contraindicated in cases of active gastric ulcers or hypersensitivity to the substance.

General data about MUCOTREIS 50mg / ml

  • Substance: carbocisteine
  • Date of last drug list: 01-07-2013
  • Commercial code: W00849001
  • Concentration: 50mg / ml
  • Pharmaceutical form: syrup
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Pharmaceutical forms available for carbocisteine

Concentrations available for carbocisteine

  • 100mg/5ml
  • 2%
  • 20mg/ml
  • 250mg/5ml
  • 300mg
  • 5%
  • 50mg/ml
  • 750mg/15ml
  • 9%